Difficulty: Medium
Average Score: 63%
Practice
Mrs. Good, a diabetic, states that she has taken the oral hypoglycemic, phenformin hydrochloride (DBI), for years. From this information, the nurse knows that Mrs. Good
Correct answer
A
Rationale
The correct answer is A) Mrs. Good has not been receiving close medical supervision. This is because phenformin hydrochloride (DBI) has been withdrawn from the market due to its association with lactic acidosis, a serious side effect. Therefore, the fact that Mrs. Good has been taking this medication for years indicates a lack of close medical supervision, as a healthcare provider would have likely switched her to a safer medication.
Option B) Mrs. Good having moderately severe diabetes cannot be determined solely based on her use of phenformin hydrochloride. The severity of diabetes is assessed through various factors such as blood sugar levels, complications, and treatment response.
Option C) Mrs. Good having active beta-cell function is not related to her use of phenformin hydrochloride. Beta-cell function is determined through specific tests assessing insulin production by the pancreas.
Option D) Mrs. Good needing to switch to insulin therapy cannot be conclusively inferred from her use of phenformin hydrochloride. The decision to switch to insulin therapy depends on various factors including blood sugar control, medication effectiveness, and individual patient needs.
In an educational context, this question highlights the importance of medication safety and close medical supervision for patients with chronic conditions like diabetes. It emphasizes the need for healthcare providers to regularly review and adjust treatment plans to ensure optimal patient outcomes and avoid potential risks associated with medications.
Option B) Mrs. Good having moderately severe diabetes cannot be determined solely based on her use of phenformin hydrochloride. The severity of diabetes is assessed through various factors such as blood sugar levels, complications, and treatment response.
Option C) Mrs. Good having active beta-cell function is not related to her use of phenformin hydrochloride. Beta-cell function is determined through specific tests assessing insulin production by the pancreas.
Option D) Mrs. Good needing to switch to insulin therapy cannot be conclusively inferred from her use of phenformin hydrochloride. The decision to switch to insulin therapy depends on various factors including blood sugar control, medication effectiveness, and individual patient needs.
In an educational context, this question highlights the importance of medication safety and close medical supervision for patients with chronic conditions like diabetes. It emphasizes the need for healthcare providers to regularly review and adjust treatment plans to ensure optimal patient outcomes and avoid potential risks associated with medications.